Unauthorized GLP-1 Knockoffs Risk Patient Safety and Future Innovation, New PRI Brief Warns
As federal regulators intensify enforcement against companies selling unauthorized knockoffs of blockbuster weight-loss drugs, a new Pacific Research Institute brief warns that the booming GLP-1 knockoff market is creating patient safety risks while undermining future breakthrough medicines. “GLP-1s are among the most promising medical breakthroughs in decades, helping patients struggling with diabetes, obesity and other chronic illnesses,” said Dr. Wayne Winegarden, director of PRI’s Center for Medical Economics and Innovation and the brief’s author. “But ...
New Study: Medicare’s Price Controls Are Fueling America’s Growing Doctor Shortage
The Pacific Research Institute’s Center for Medical Economics and Innovation today released a new issue brief warning that continued federal underpayment of doctors is fueling a looming healthcare crisis by accelerating the nation’s physician shortage and undermining access to care. Written by PRI senior fellow in business and economics and CMEI director Dr. Wayne Winegarden, the brief (titled “It’s Time for Medicare to Stop Shortchanging Physicians”) finds that Medicare reimbursement rates are well below market ...
The FDA’s sunscreen rules leave Americans exposed
Just in time for the beginning of summer, the Food and Drug Administration has approved a new sunscreen ingredient for the first time in more than a quarter-century. Bemotrizinol is a next-generation ultraviolet filter already widely used in other nations. The FDA fully approved the ingredient for use in the United States this month, after proposing a potential approval late last year. It’s progress, but it does not address the deeper problem. The FDA still ...
Trending Topics
Studies
